Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coudert

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2011
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyB Coudert, T Ciuleanu, K Park, et al.
Annales De Cardiologie Et D'Angeiologie|January 1, 1987
[Tricuspid endocarditis with right-left auricular shunt through a patent foramen ovale]P Morelon, J C Eicher, P Chavanet, et al.
Bulletin Du Cancer|January 22, 1998
[Clinical value of the estimation of growth kinetics of primary ovarian cancer recurrences by CA125 doubling time]J M Riedinger, B Coudert, I Barillot, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
The American Journal of Emergency Medicine|May 13, 2004
Can severe acute pain escape visual analog scale screening in the ED?Kolia G Milojevic, J-P Cantineau, R Ruiz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival modelP Foucher, B Coudert, P Arveux, et al.
Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.
Clinical Cardiology|October 2, 1998
Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiographyY Cottin, C Touzery, F Dalloz, et al.
European Journal of Nuclear Medicine|May 1, 1996
Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of womenY Cottin, C Touzery, B Coudert, et al.
Anticancer Research|January 12, 2000
MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patientsS Lizard-Nacol, P Genne, B Coudert, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2011
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyB Coudert, T Ciuleanu, K Park, et al.
Annales De Cardiologie Et D'Angeiologie|January 1, 1987
[Tricuspid endocarditis with right-left auricular shunt through a patent foramen ovale]P Morelon, J C Eicher, P Chavanet, et al.
Bulletin Du Cancer|January 22, 1998
[Clinical value of the estimation of growth kinetics of primary ovarian cancer recurrences by CA125 doubling time]J M Riedinger, B Coudert, I Barillot, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
The American Journal of Emergency Medicine|May 13, 2004
Can severe acute pain escape visual analog scale screening in the ED?Kolia G Milojevic, J-P Cantineau, R Ruiz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival modelP Foucher, B Coudert, P Arveux, et al.
Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.
Clinical Cardiology|October 2, 1998
Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiographyY Cottin, C Touzery, F Dalloz, et al.
European Journal of Nuclear Medicine|May 1, 1996
Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of womenY Cottin, C Touzery, B Coudert, et al.
Anticancer Research|January 12, 2000
MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patientsS Lizard-Nacol, P Genne, B Coudert, et al.
Pageof 10